Exit Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Exit Wealth Advisors's BMY Position: Q2 2026 in Review
Exit Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $461K and bringing the position to 53,008 shares worth $3.05M. The position accounts for 1.39% of the portfolio, ranked #19.
Exit Wealth Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Exit Wealth Advisors held 53,008 shares of Bristol-Myers Squibb worth $3.05M as of Q2 2026.
- Exit Wealth Advisors bought 8,037 Bristol-Myers Squibb shares in Q2 2026, an estimated $461K.
- Bristol-Myers Squibb made up 1.39% of Exit Wealth Advisors's portfolio in Q2 2026, its #19 holding.
- Exit Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Exit Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.